Clinical Trials
8 trialsNCT00001337 2025-06-22
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02609386 2024-01-30
INSPIRE
Brooklyn ImmunoTherapeutics, LLC
Phase 2 Completed
NCT02595372 2021-12-15
Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy
Indiana University
Phase 2 Completed
NCT00210470 2020-12-11
A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
Brooklyn ImmunoTherapeutics, LLC
Phase 2 Completed
NCT00002682 2018-10-24
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00001191 2017-07-02
The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02518373 2015-08-07
CC5
Cancer Advances Inc.
Phase 2 Completed
NCT00003151 2012-07-02
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed